Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-25T04:21:00.338Z Has data issue: false hasContentIssue false

13 - Type 2 diabetes

Published online by Cambridge University Press:  06 December 2010

Judith C. Ahronheim ,
Zheng-Bo Huang ,
Vincent Yen ,
Christina Davitt  and
David Barile
Judith C. Ahronheim
Affiliation:
State University of New York, Downstate Medical Centre
Zheng-Bo Huang
Affiliation:
Cornell University, New York
Vincent Yen
Affiliation:
New York Medical College
Christina Davitt
Affiliation:
Seton Hall University, New Jersey
David Barile
Affiliation:
Drexel University, Philadelphia
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Case Studies in Geriatric Medicine , pp. 81 - 87
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ben-Ami, H., Nagachandran, P., Mendelson, A.et al. (1999). Drug induced hypoglycemic coma in 102 diabetic patients. Archives of Internal Medicine, 159, 281–4CrossRefGoogle ScholarPubMed
Weverling-Rijnsburger, A. W., Blauw, G. J., Lagaay, A. M.et al. (1997). Total cholesterol and the risk of mortality in the oldest old. Lancet, 350, 1119–23CrossRefGoogle ScholarPubMed
Beebe, K. and Patel, J. (1999). Rosiglitazone is effective and well tolerated in patients over 65 years with type 2 diabetes. Diabetes, 42 Suppl 1, A111Google Scholar
Carlsson, C. M., Carnes, M, McBride, P. E.et al. (1999). Managing dyslipidemia in the elderly. Journal of the American Geriatrics Society, 47, 1458–65CrossRefGoogle Scholar
Coscelli, C., Lostia, S. A., Lunetta, M.et al. (1995). Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Research and Clinical Practice, 28, 173–7CrossRefGoogle ScholarPubMed
DeFronzo, R. A. (1999). Pharmacologic therapy for type 2 diabetes mellitus. Annals of Internal Medicine, 131, 281–303CrossRefGoogle ScholarPubMed
Groop, L. C., Bottazzo, G. F., and Doniach, D. (1986). Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes, 35, 237–41CrossRefGoogle Scholar
Grundy, S. M., Cleeman, J. I., Rifkind, B. H.et al., for the Coordinating Committee of the National Cholesterol Education Program (1999). Cholesterol lowering in the elderly population. Archives of Internal Medicine, 159, 1670–8CrossRefGoogle ScholarPubMed
Heart Outcomes Prevention Evaluation Study Investigators (2000). Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet, 22, 253–9
Hunt, D. H., Young, P. Y., Simes, J.et al., for the LIPID investigators (2001). Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial. Annals of Internal Medicine, 134, 931–40CrossRefGoogle ScholarPubMed
Lewis, S. J., Moye, L. A., Sacks, F. M.et al. (1998). Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol in the average range: results of the Cholesterol and Recurrent Events (CARE) trial. Annals of Internal Medicine, 129, 681–9CrossRefGoogle ScholarPubMed
Mahler, R. J. and Adler, M. L. (1999). Type 2 diabetes mellitus: update on diagnosis, pathophysiology and treatment. Journal of Clinical Endocrinology and Metabolism, 84, 1165–71CrossRefGoogle ScholarPubMed
Meneilly, G. S. and Tessier, D. (2001). Diabetes in elderly adults. Journals of Gerontology: Medical Sciences, 56A, M5–13CrossRefGoogle Scholar
Parulkar, A. A., Pendergrass, M. L., Granda-Ayala, R. L.et al. (2001). Nonhypoglycemic effects of thiazolidinediones. Annals of Internal Medicine, 134, 61–71CrossRefGoogle ScholarPubMed
Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N.et al. (2002). ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation, 106, 1024–8Google ScholarPubMed
Saito, I., Folsom, A. R., Brancati, F. L.et al. (2000). Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Annals of Internal Medicine, 133, 81–91CrossRefGoogle ScholarPubMed
Shepherd, J., Blauw, G. J., Murphy, M. B.et al. (2002). Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet, 360, 1623–30CrossRefGoogle Scholar
Shorr, R. I., Ray, W. A., Daughterty, J. R.et al. (1997). Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Archives of Internal Medicine, 157, 1681–6CrossRefGoogle ScholarPubMed
Stratton, I. M., Adler, A. I., Neil, H. A.et al., for the UKPDS Study Group. (2000). Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal, 321, 405–12CrossRefGoogle Scholar
Turner, R. C., Cull, C., Frighi, V.et al., for the UKPDS study group (1999). Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). Journal of the American Medical Association, 281, 2005–12CrossRefGoogle Scholar
UKPDS Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352, 837–9CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×